Navigation Links
Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
Date:10/25/2010

ge diluted shares for adjusted EPS for the third quarter of 2010 were 962 million versus 1,021 million for the third quarter of 2009.

Capital expenditures for the third quarter of 2010 were $127 million versus $130 million for the third quarter of 2009.  Worldwide cash and marketable securities were $17.0 billion and adjusted outstanding debt was $13.7 billion as of Sept. 30, 2010.  The Company’s adjusted outstanding debt excludes the impact of a change in accounting on the carrying values of its convertible notes.  The Company’s outstanding debt presented in accordance with GAAP was $13.3 billion as of Sept. 30, 2010.

2010 Guidance UpdateThe Company reaffirmed both revenue and adjusted EPS guidance at slightly below $15.1 billion and towards lower end of $5.05 to $5.25, respectively.

Included in the 2010 revenue and Adjusted EPS guidance noted above is the estimated impact of the U.S. Health Care Reform Legislation of slightly below $200 million.  

The Company now expects the 2010 adjusted tax rate to be around 20 percent and continues to expect capital expenditures to be approximately $600 million.

Adjusted EPS and the adjusted tax rate exclude stock option expense, certain expenses related to prior acquisitions, the non-cash interest expense resulting from a change in accounting for our convertible notes, and the income tax benefit as a result of resolving certain non-routine transfer pricing issues with tax authorities.

Third Quarter Product and Pipeline UpdateThe Company provided updates on selected products and clinical programs.

Aranesp:  The Company discussed the U.S. Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) panel meeting which took place on Oct. 18, 2010.  The purpose of the panel was to review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy), conducte
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges
2. WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call
3. Roper Industries Announces Record Third Quarter Results
4. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
5. China Medicine to Announce Third Quarter 2010 Financial Results on November 10, 2010
6. Bacterin International Holdings, Inc. Schedules Conference Call to Present Third Quarter 2010 Financial Results
7. Thoratec Schedules Third Quarter Conference Call, Webcast
8. Essilor - Third-Quarter 2010 Report
9. CVS Caremark Corporation to Hold Third Quarter 2010 Conference Call
10. VirtualScopics Schedules Third Quarter 2010 Earnings Announcement
11. Danaher Reports Record Third Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 The ... http://www.morcellatorlawsuit2015.com )  in hysterectomies and myomectomies (procedures to remove ... that the FBI is investigating Johnson & Johnson,s ... manufacturer of the devices. According to the report ... 27 th , the FBI is trying to ...
(Date:5/28/2015)... Research and Markets ( ... the  "North America Ultrasound Devices Market - ...  report to their offering.       ... type of imaging. It uses high-frequency sound ... structures inside the body. Health care experts ...
(Date:5/28/2015)... 2015 The Parenteral Drug Association (PDA) ... organization of the Johnson & Johnson Kilmer Conference ... Johnson & Johnson (J&J) is reviving the ... in endoscopes. J&J ran 8 conferences on sterilization, ... 2003 on advances in sterilization and other topics. ...
Breaking Medicine Technology:Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3North America Ultrasound Devices Market Report 2014-2019 - Technology and Applications 2PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
... Aug. 29, 2011 Elekta announced it has ... treatment control system in the European Union. Integrity ... variable dose rate (CVDR) and interdigitation capabilities for ... complete range of delivery techniques -- such as ...
... Cardium Therapeutics (NYSE Amex: CXM ) ... designed to reestablish compliance with its exchange listing requirements ... of a revenue-generating nutraceutical business designed to expand the ... Company announced the incorporation of MedPodium Health Sciences, Inc., ...
Cached Medicine Technology:New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent 2New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent 3Cardium Provides Update on Exchange Listing and Related Business Matters 2Cardium Provides Update on Exchange Listing and Related Business Matters 3Cardium Provides Update on Exchange Listing and Related Business Matters 4Cardium Provides Update on Exchange Listing and Related Business Matters 5
(Date:5/28/2015)... (PRWEB) May 28, 2015 Senior Housing ... legend Lou Piniella, who managed the Seattle Mariners team ... Piniella will appear in television and digital advertising for ... living apartment communities, including several new communities slated to ... Bellevue, Bothell, Lynnwood, Mountlake Terrace, Tukwila, and University Place. ...
(Date:5/28/2015)... 28, 2015 More than 300 locations ... raise money to help the Muscular Dystrophy Association save ... and related life-threatening diseases that limit muscle strength and ... program. , From June 1 to June 30, sweetFrog ... the opportunity to help send local children affected by ...
(Date:5/28/2015)... Jacksonville, Fla. (PRWEB) May 28, 2015 ... center dedicated to patients suffering from acute stroke or ... Emergency Medicine is one of a few in the ... and other neurological emergency needs such as brain aneurysms. ... facilities to take care of patients who are impacted ...
(Date:5/28/2015)... May 28, 2015 ZH Healthcare (ZH), ... that it is releasing BlueEHS, the Electronic Health Solution, ... Image for the benefit of all AWS users worldwide. ... a first of its kind, Freemium, SaaS, Electronic Health ... Records (EHR) with an integrated practice management system (PMS), ...
(Date:5/28/2015)... Edmond, OK (PRWEB) May 28, 2015 ... pain relief lotion and products, today announced their best-selling lotion ... bottle. Real Time Pain Relief is an FDA registered OTC ... natural and herbal ingredients, such as Aloe Vera, Arnica, Capsicum, ... a low level of Menthol – only 1.25% – to ...
Breaking Medicine News(10 mins):Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 3Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2
... 5 NeurogesX, Inc.,(Nasdaq: NGSX ), a ... management therapies, announced today that it is,scheduled to ... Seventh Annual,Needham & Company Biotechnology and Medical Technology ... be presenting at the,conference and will be available ...
... 5 Charterhouse Group, Inc.,("Charterhouse") a New ... and supported growing middle-market companies since 1973,announced ... Partners,("Highlander") and MTS Health Investors ("MTS") to ... Inc. ("CEA" or the "Company"), the,market leader ...
... Leads Combination to Form Nation,s, Foremost Distributor ... SYLMAR, Calif. and DUBLIN, Ohio, June 5 ... and a leading,distributor of emergency medical services (EMS) ... of EMS products, announced today,that they have merged ...
... Detecting CXCR4 HIV-1 Levels as Low as 0.3%, ... Monogram,Biosciences, Inc. (Nasdaq: MGRM ) today announced ... Trofile was introduced,commercially upon FDA approval of Selzentry(TM) ... 2007. Optimization of Monogram,s,Trofile(TM) HIV co-receptor tropism assay ...
... Jeffery Sterman, Public Affairs,Director and voice of Kaiser ... discrimination and breach of contract. A person with AIDS,Sterman ... response to HIV,and AIDS., David J. St. Louis, ... San Francisco and Kaiser Foundation Health Plan was,served June ...
... downplay antibiotic treatment for longstanding symptoms, PORTLAND, Ore., ... into the woods, it also exposes them to tick ... fastest growing infectious diseases in,the United States. A microscopic ... the Lyme infection. Although the,incidence of Lyme disease remains ...
Cached Medicine News:Health News:NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference 2Health News:NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference 3Health News:Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals 2Health News:Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals 3Health News:Tri-anim and Bound Tree Medical Merge to Create Nation's Leading Specialty Health Care Distributor 2Health News:Tri-anim and Bound Tree Medical Merge to Create Nation's Leading Specialty Health Care Distributor 3Health News:Tri-anim and Bound Tree Medical Merge to Create Nation's Leading Specialty Health Care Distributor 4Health News:Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay 2Health News:Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay 3Health News:Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay 4Health News:Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay 5Health News:Kaiser Permanente Sued By Executive for AIDS Discrimination 2Health News:When Are Antibiotics for Lyme Disease Medically Necessary? 2Health News:When Are Antibiotics for Lyme Disease Medically Necessary? 3
2.5 mm cups angled 50 degrees, 10 mm from angle to tip. Serrated handle with polished finish....
Tennant straight tying forceps, 6.0 mm tying platforms, with pin, extra delicate smooth jaws....
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Gills Colibri forceps, very fine pointed tips....
Medicine Products: